详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Shi Yu-Ying[1] * ; Fan Gang[2] ; Tan Ruirong[3] ; Li Shan[1] ; Sun Hua-Bing[4] ; Li Rui[5] ; Yang Mengni[3] ; Gao Shanshan[6] ; Liu Miao[7] ; Dai Meng-Yuan[8] ;

机构： [1]Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China. [2]Department of Urology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, China. [3]China Translational Chinese Medicine Key Laboratory of Sichuan Province, State Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China. [4]Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China. [5]Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Chengdu, China. [6]Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Taipa, Macau, China. [7]Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. mliu0@bwh.harvard.edu. [8]Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China. mengyuandai@whu.edu.cn.

出处：

DOI：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2024]版：

无

最新[2023]版：

大类 | 1 区

生物学

小类 | 2 区细胞生物学

第一作者：

第一作者机构： [1]Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

Correction: Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates

文献详情